Clinical Study Results Medicines, including Rare Diseases

Important

Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country.

This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

Clinical study results Sanofi pharma, including Sanofi Genzyme – Letter A
Generic NameTrade NameCondition(s)Study CodeStudy NameAccess to Study / ProtocolAccess to Results
AAV2-SFLT01Not Marketed
Age-Related Macular Degeneration
MSC12870NANCT01024998Publication's Reference
ABCA4 GENE THERAPYNot Marketed
Stargardt's Disease
TDU13583NAEudraCT: 2010-023111-34Tabulated Results
AFLIBERCEPT
Zaltrap
Colorectal cancer
AFLIBC06097NAEudraCT: 2011-005724-17Tabulated Results
AFLIBERCEPT
Zaltrap
Colorectal cancer
AFLIBL06266AFEQTNCT01670721Tabulated Results
AFLIBERCEPT
Zaltrap
Non Hodgkins Lymphoma
TCD10173NANCT00644124Summary
AFLIBERCEPT
Zaltrap
Colorectal cancer
EFC11885NANCT01882868Tabulated Results
AFLIBERCEPT
Zaltrap
Colorectal cancer
EFC11338AFLAMENCT01661270Tabulated Results
AFLIBERCEPT
Zaltrap
Cancer
TCD6117NASummary
AFLIBERCEPT
Zaltrap
Colorectal cancer
AFLIBC06561AMORNCT01955629Summary
AFLIBERCEPT
Zaltrap
Cancer
TCD11470NANCT01930552Summary
AFLIBERCEPT
Zaltrap
Cancer
TCD11382NANCT01148615Summary
AFLIBERCEPT
Zaltrap
Cancer
EFC10668AFFIRMNCT00851084Tabulated Results
AFLIBERCEPT
Zaltrap
Cancer
EFC10547VANILLANCT00574275Tabulated Results
AFLIBERCEPT
Zaltrap
Cancer
EFC10261VITALNCT00532155Tabulated Results
AFLIBERCEPT
Zaltrap
Cancer
EFC10262VELOURNCT00561470Tabulated Results
AFLIBERCEPT
Zaltrap
Cancer
ARD6772NANCT00396591Tabulated Results
AFLIBERCEPT
Zaltrap
Cancer
EFC6546NANCT00519285Tabulated Results
AFLIBERCEPT
Zaltrap
Cancer
EFC6125NANCT00327444Tabulated Results
AFLIBERCEPT
Zaltrap
Cancer
ARD6123NANCT00284141Tabulated Results
AFLIBERCEPT
Zaltrap
Cancer
ARD6122NANCT00327171Tabulated Results
AFLIBERCEPT
Zaltrap
Cancer
TES10897QUTIEEudraCT: 2008-006796-80Summary
AGALSIDASE BETA
Fabrazyme
Fabry Disease
FB9702-01*NASummary
AGALSIDASE BETA
Fabrazyme
Fabry Disease
DIREGC07006NANCT00196742 Publication Reference
AGALSIDASE BETA
Fabrazyme
Fabry Disease
AGAL19412NANCT01650779Tabulated Results
AGALSIDASE BETA
Fabrazyme
Fabry Disease
AGAL19110NAEudraCT: 2012-001966-14Tabulated Results
AGALSIDASE BETA
Fabrazyme
Fabry Disease
AGAL-1-002-98*NASummary
AGALSIDASE BETA
Fabrazyme
Fabry Disease
AGAL03204NANCT00140621Tabulated Results
AGALSIDASE BETA
Fabrazyme
Fabry Disease
AGAL06207FIELDNCT00701415Tabulated Results
AGALSIDASE BETA
Fabrazyme
Fabry Disease
AGAL02503NANCT00081497Tabulated Results
AGALSIDASE BETA
Fabrazyme
Fabry Disease
AGAL-022-02NANCT00837824Tabulated Results
AGALSIDASE BETA
Fabry Disease
Fabry Disease
AGAL-019-01*NASummary
AGALSIDASE BETA
Fabrazyme
Fabry Disease
AGAL-017-01NANCT00196716Tabulated Results
AGALSIDASE BETA
Fabrazyme
Fabry Disease
AGAL-016-01NANCT00074958Tabulated Results
AGALSIDASE BETA
Fabrazyme
Fabry Disease
AGAL-008-00NANCT00074984Tabulated Results
AGALSIDASE BETA
Fabrazyme
Fabry Disease
AGAL-007-99*NASummary
AGALSIDASE BETA
Fabrazyme
Fabry Disease
AGAL-006-99*NASummary
AGALSIDASE BETA
Fabrazyme
Fabry Disease
AGAL-005-99NANCT00074971Publication's reference
ALEMTUZUMAB
Lemtrada
Multiple Sclerosis
OBS13436NANCT03774914Abstract
ALEMTUZUMAB
Lemtrada
Multiple Sclerosis
TDU14981NANCT02977533Summary
ALEMTUZUMAB
Lemtrada
Multiple Sclerosis
TDU13475NANCT02282826Summary
ALEMTUZUMAB
Lemtrada
Multiple Sclerosis
TDU14260SCALANCT02583594Summary
ALEMTUZUMAB
Lemtrada
Multiple Sclerosis
LPS13650EMERALDEudraCT: 2014-000092-62Tabulated Results
ALEMTUZUMAB
Lemtrada
Multiple Sclerosis
LPS13649TOPAZNCT02255656Tabulated Results
ALEMTUZUMAB
Lemtrada
Multiple Sclerosis
CAMMS03409CARE-MS IINCT00548405Tabulated Results
ALEMTUZUMAB
Lemtrada
Multiple Sclerosis
CAMMS32400507CARE-MS IINCT00548405Tabulated Results
ALEMTUZUMAB
Lemtrada
Multiple Sclerosisa
CAMMS323CARE-MS INCT00530348Tabulated Results
ALEMTUZUMAB
Lemtrada
Multiple Sclerosis
CAMMS223NANCT00050778Tabulated Results
ALEMTUZUMAB
Lemtrada
Multiple Sclerosis
ASY15905LEMTRADA-ITPNCT03784898Tabulated Results
ALEMTUZUMAB
Lemtrada
Multiple Sclerosis
ALEMLL08091LemCourseEudraCT: 2016-000464-42Tabulated Results
ALEMTUZUMAB
Campath
Leukemia
CAM314NANCT00086580Tabulated Results
ALEMTUZUMAB
Campath
Leukemia
CAM307*NANCT00046683Summary
ALEMTUZUMAB
Campath
Leukemia
CAM211*NASummary
ALEMTUZUMAB
Campath
Leukemia
CAM203NANCT00328198Tabulated Results
ALFUZOSIN
Uroxatral, Xatral
Prostatic Diseases
PM_L_0168ALFONE CHINANCT00280605Summary
ALFUZOSIN
Uroxatral, Xatral
Urinary Bladder Neurogenic
PKM6270ALPHACHIPNCT00629720Summary
ALFUZOSIN
Uroxatral, Xatral
Benign Prostatic Hyperplasia
LTS5235NANCT00347061Summary
ALFUZOSIN
Uroxatral, Xatral
Calculi
L_9795ALF-STONEEudraCT: 2005-005481-36Summary
ALFUZOSIN
Uroxatral, Xatral
Prostatic Diseases
L_9645NANCT00336921Summary
ALFUZOSIN
Uroxatral, Xatral
Urologic Diseases
L_9397ALF-RIKNCT00453908Summary
ALFUZOSIN
Uroxatral, Xatral
Prostatic Diseases
L_8935ALEX-XLNCT00575913Summary
ALFUZOSIN
Uroxatral, Xatral
Prostatic Diseases
L_8819NANCT00542165Summary
ALFUZOSIN
Uroxatral, Xatral
Prostatic Diseases
L_8758NANCT00637715Summary
ALFUZOSIN
Uroxatral, Xatral
Prostatic Diseases
L_8472ALF-ACUTENCT00540891Summary
ALFUZOSIN
Uroxatral, Xatral
Hydronephosis Neurogenic Bladder
EFC6269ALPHAHYDRONCT00576823Tabulated Results
ALFUZOSIN
Uroxatral, Xatral
Benign Prostatic Hyperplasia
EFC5791NANCT00399464Summary
ALFUZOSIN
Uroxatral, Xatral
Neurogenic Urinary Bladder
EFC5722ALPHACHINNCT00549939Tabulated Results
ALFUZOSIN
Uroxatral, Xatral
Benign Prostatic Hyperplasia
EFC4485ALFAURUSNCT00029822Publication's reference
ALFUZOSIN
Uroxatral, Xatral
Benign Prostatic Hyperplasia
EFC4428ALFAURUSNCT00290030Summary
ALFUZOSIN
Uroxatral, Xatral
Benign Prostatic Hyperplasia
DRI5234NANCT00409357Summary
ALFUZOSIN
Uroxatral, Xatral
Prostatic Diseases
ALFUS_L_01667SAMBANCT00486785Summary
ALFUZOSIN
Uroxatral, Xatral
Prostatic Diseases
ALFUS_L_01241SAMBA_THAILANDNCT00401661Summary
ALGLUCOSIDASE ALFA
Myozyme®/Lumizyme®
Pompe Disease
AGLU06909/LTS13930NANCT01710813Abstract
ALGLUCOSIDASE ALFA
Myozyme® Lumizyme®
Pompe Disease; Glycogen Storage Disease Type II (GSD II); Acid Maltase Deficiency Disease
LTS12869NANCT00486889Tabulated Results
ALGLUCOSIDASE ALFA
Myozyme
Pompe Disease
ALGMYL08718APOLLO-IOPDEudraCT: 2021-004047-25Tabulated Results
ALGLUCOSIDASE ALFA
Myozyme
Pompe Disease
AGLU09411NANCT01526785Tabulated Results
ALGLUCOSIDASE ALFA
Myozyme
Pompe Disease
AGLU07510NANCT01597596Tabulated Results
ALGLUCOSIDASE ALFA
Myozyme
Pompe Disease
AGLU07310NANCT01288027Tabulated Results
ALGLUCOSIDASE ALFA
Myozyme
Pompe Disease
AGLU03807NANCT00701129Tabulated Results
ALGLUCOSIDASE ALFA
Myozyme
Pompe Disease
AGLU03707_MSC12817NAEudraCT: 2015-000583-34Tabulated Results
ALGLUCOSIDASE ALFA
Myozyme
Pompe Disease
AGLU03306NANCT00483379Tabulated Results
ALGLUCOSIDASE ALFA
Myozyme
Pompe Disease
AGLU03206NANCT00455195Tabulated Results
ALGLUCOSIDASE ALFA
Myozyme
Pompe Disease
AGLU02804NAEudraCT: 2005-002829-31Summary
ALGLUCOSIDASE ALFA
Myozyme
Pompe Disease
AGLU02704NANCT00158600Tabulated Results
ALGLUCOSIDASE ALFA
Myozyme
Pompe Disease
AGLU01702NAEudraCT: 2004-002168-59Summary
ALGLUCOSIDASE ALFA
Myozyme
Pompe Disease
AGLU01602NANCT00059280Publication's Reference
ALIROCUMAB
Praluent
Cardiovascular Diseases
EFC11570NANCT01663402Tabulated Results
ALIROCUMAB
Praluent
Hypercholesterolemia
POP12671NANCT01670734Summary
ALIROCUMAB
Praluent
Hypercholesterolemia
MSC14864NANCT03415178Tabulated Results
ALIROCUMAB
Praluent
Hypercholesterolemia
LTS13463ODYSSEY OLEEudraCT: 2013-002572-40Tabulated Results
ALIROCUMAB
Praluent
Hypercholesterolemia
LTS11717ODYSSEY LONG TERMNCT01507831Tabulated Results
ALIROCUMAB
Praluent
Hypercholesterolemia
LPS14355ODYSSEY DM-InsulinNCT02585778Tabulated Results
ALIROCUMAB
Praluent
Hypercholesterolemia
LPS14245ODYSSEY APPRISENCT02476006Tabulated Results
ALIROCUMAB
Praluent
Dyslipidemia
LPS14354ODYSSEY DM-DyslipidemiaNCT02642159Tabulated Results
ALIROCUMAB
Praluent
Hypercholesterolemia
EFC14660NANCT03510715Tabulated Results
ALIROCUMAB
Praluent
Hypercholesterolemia
EFC14305ODYSSEY-NIPPONNCT02584504Tabulated Results
ALIROCUMAB
Praluent
Hypercholesterolemia
EFC13889ODYSSEY EASTNCT02715726Tabulated Results
ALIROCUMAB
Praluent
Hypercholesterolemia
EFC13786ODYSSEY CHOICE IINCT02023879Tabulated Results
ALIROCUMAB
Praluent
Hypercholesterolemia
EFC13672ODYSSEY JAPANNCT02107898Tabulated Results
ALIROCUMAB
Praluent
Hypercholesterolemia
EFC12732ODYSSEY HIGH FHNCT01617655Tabulated Results
ALIROCUMAB
Praluent
Hypercholesterolemia
EFC12492ODYSSEY FH INCT01623115Tabulated Results
ALIROCUMAB
Praluent
Hypercholesterolemia
EFC11716ODYSSEY MONONCT01644474Tabulated Results
ALIROCUMAB
Praluent
Hypercholesterolemia
EFC11569ODYSSEY COMBO IINCT01644188Tabulated Results
ALIROCUMAB
Praluent
Hypercholesterolemia
EFC11568ODYSSEY COMBO INCT01644175Tabulated Results
ALIROCUMAB
Praluent
Hypercholesterolemia
EFC14074NANCT02289963Tabulated Results
ALIROCUMAB
Praluent
Hypercholesterolemia
DFI14223ODYSSEY KIDSEudraCT: 2015-003766-85Tabulated Results
ALIROCUMAB
Praluent
Hypercholesterolemia
DFI12361NANCT01812707Tabulated Results
ALIROCUMAB
Praluent
Hypercholesterolemia
DFI11566NANCT01288469Tabulated Results
ALIROCUMAB
Praluent
Hypercholesterolemia
DFI11565NANCT01288443Tabulated Results
ALIROCUMAB
Praluent
Acute Coronary Syndrome
ALIROL08069ODYSSEY J-IVUSNCT02984982Tabulated Results
Alogliptin
Nesina
Diabetes Mellitus, Type 2
ALOGLC08867ACADEMICNCT03794336Publication reference
AMBROXOL
Not marketed
Acute Pharyngitis
LPS15328DELICIOUSNCT03583658Summary
Amcenestrant
Not marketed
Breast Cancer
ACT16106AMEERA-4NCT04191382Tabulated Results
AMIBEGRON
Not marketed
Major Depressive Disorder
LTS4848NAEudraCT: 2005-000577-21Summary Results
AMIBEGRON
Not marketed
Generalized anxiety disorder
LTE5894VEGAEudraCT: 2006-002253-71Summary Results
AMIBEGRON
Not marketed
Major Depressive Disorder
LTE5376CALYPSOEudraCT: 2005-004006-81Summary Results
AMIBEGRON
Not marketed
Major Depressive Disorder
EFC6607SIRIUSNCT00385307Summary
AMIBEGRON
Not marketed
Major Depressive Disorder
EFC6224ALBERIOEudraCT: 2006-004146-16Summary Results
AMIBEGRON
Not marketed
Generalized anxiety disorder
EFC5895GEMINIEudraCT: 2006-004147-33Summary Results
AMIBEGRON
Not marketed
Generalized anxiety disorder
EFC5893AQUARIUSEudraCT: 2005-003181-41Summary
AMIBEGRON
Not marketed
Generalized anxiety disorder
EFC5892LIBRANCT00252343Summary
AMIBEGRON
Not marketed
Generalized anxiety disorder
EFC5891ELECTRAEudraCT: 2005-003180-23Summary
AMIBEGRON
Not marketed
Major Depressive Disorder
EFC5379NANCT00825019Summary
AMIBEGRON
Not marketed
Major Depressive Disorder
EFC5374NANCT00825058Summary
AMIBEGRON
Not marketed
Major Depressive Disorder
EFC5116PHOENIXNCT00252330Summary
AMIBEGRON
Not marketed
Major Depressive Disorder
EFC5041ORIONNCT00252356Summary
AMIBEGRON
Not marketed
Major Depressive Disorder
EFC4846ZEPHIRNCT00319709Summary
AMISULPRIDE
Solian
Schizophrenia
AMISUL06155ESCAPENCT01795183Summary
AMISULPRIDE
Solian
Schizophrenia
PM_L_0055SOLIACSEudraCT: 2004-004461-15Summary Results
AMISULPRIDE
Solian
Schizophrenia
L_9517ASAPNCT00436371Summary
AMISULPRIDE
Solian
Schizophrenia
L_8968NANCT00331981Summary
AMISULPRIDE
Solian
Schizophrenia
L_8967AMIRISMINDSummary
AMISULPRIDE
Solian
Bipolar Disorder
C_8428SOLMANIANCT00126009Summary
AMISULPRIDE
Solian
Schizophrenia
AMISU_L_01008AMIMINDEudraCT: 2007-005772-13Summary Results
AMLITELIMAB
Not marketed
Atopic Dermatitis
ACT17369NAEudraCT: 2018-002299-41Tabulated Results
anti-CD52 antibody
Not marketed
Multiple Sclerosis
LTS14120NANCT02313285Summary
ANTI-CXCR5 MAB
Not marketed
Systemic Lupus Erythematosus
TDR11407NANCT02321709Summary
ANTI-PNAG MONOCLONAL ANTIBODY
Not marketed
Infection prophylaxis
PKD11791NANCT01389700Summary
ANTI-THYMOCYTE GLOBULIN (RABBIT)
Thymoglobulin
kidney transplant rejection
SMC-534-1003*NASummary
ANTI-THYMOCYTE GLOBULIN (RABBIT)
Thymoglobulin
kidney transplant rejection
SMC-101-1009*NASummary
ANTI-THYMOCYTE GLOBULIN (RABBIT)
Thymoglobulin
kidney transplant rejection
SMC-101-1008*NASummary
ANTI-THYMOCYTE GLOBULIN (RABBIT)
Thymoglobulin
kidney transplant rejection
SMC-101-1007*NASummary
ANTI-THYMOCYTE GLOBULIN (RABBIT)
Thymoglobulin
kidney transplant rejection
SMC-101-1002*NASummary
ANTI-THYMOCYTE GLOBULIN (RABBIT)
Thymoglobulin
kidney transplant rejection
SANG-96-3-K-THY-I*NASummary
ANTI-THYMOCYTE GLOBULIN (RABBIT)
Thymoglobulin
kidney transplant rejection
SANG-93-3-K-THY-R*NASummary
ANTIBODY DRUG CONJUGATE
Not marketed
Neoplasm Malignant
TED14147NANCT02575781Summary
ANTIBODY-DRUG CONJUGATE TARGETING SIALOGLYCOTOPE CA6/HUDS6
Not marketed
Triple Negative Breast Cancer
TED10499NANCT01156870Summary
ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC FUSION PROTEIN
Eloctate
Hemophilia A
LPS16473verITI-8 StudyNCT03093480Tabulated Results
ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC FUSION PROTEIN
Eloctate
Hemophilia A
EFC16225 (997HA306)NANCT02234323Summary
ARTESUNATE
Arsucam
Malaria
PM_L_0163ATOLNCT00445796Summary
ARTESUNATE
Arsucam
Malaria
ARTEN_L_00848ACT MALINCT00452907Summary
ARTESUNATE + AMODIAQUINE
Coarsucam
Malaria
ARAMF_L_04314NANCT01023399Summary
ARTESUNATE + AMODIAQUINE
Coarsucam
Malaria
ARAMF_C_05370NANCT01378286Summary
ARTESUNATE + AMODIAQUINE
Coarsucam
Malaria
ARAMF_L_02661NANCT00699920Summary
ARTESUNATE + AMODIAQUINE
Coarsucam
Malaria
PM_L_0164ATAQ EASYNCT00316329Summary
ARTESUNATE + AMODIAQUINE
Coarsucam
Malaria
ARAMF_L_02873NANCT00540410Summary
ARTESUNATE + AMODIAQUINE
Coarsucam
Malaria
ARAMF_L_01570NANCT00386503Summary
ATACIGUAT
Not marketed
Peripheral Arterial Disease
DFI6174ACCELANCT00443287Summary
ATACIGUAT
Not marketed
Pain, Neuropathic
DFI10569SERENEATIEudraCT: 2008-001518-26Summary Results
ATORVASTATIN/IRBESARTAN
Rovelito
Diabetes Mellitus, Type 2
ATOIRL07827NANCT02842359Summary
AVANAFIL
Spedra
Erectile Dysfuntion
AVANAL07163CEDARNCT02503306Summary

References:

* These study results were previously posted on GenzymeClinicalResearch.com
** This link replaces the same summary that was previously posted